Literature DB >> 9005977

Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice.

B Ahrén1, E Simonsson, A J Scheurink, H Mulder, U Myrsén, F Sundler.   

Abstract

To study islet function following reduced insulin sensitivity, we examined mice of the C57BL/6J strain, the genotype of which carries an increased propensity to develop insulin resistance when metabolically challenged. The mice received either a high-fat diet (58% fat on an energy basis) or a control diet (11% fat) for 12 weeks. The body weight of mice on the high-fat diet increased significantly more than that of mice on the control diet (25.8 +/- 0.4 v 21.3 +/- 0.2 g, P < .001). Already after 1 week on the high-fat diet, a significant hyperglycemia accompanied by hyperinsulinemia had evolved, indicative of insulin resistance. After 12 weeks, plasma glucose levels for high-fat diet-treated mice were 7.5 +/- 0.1 mmol/L, versus 6.5 +/- 0.1 mmol/L in controls (P < .001); corresponding values for plasma insulin were 248 +/- 17 and 104 +/- 7 pmol/L, respectively (P < .001). Mice given a high-fat diet also had elevated levels of total cholesterol, triglycerides, and free fatty acids (FFAs) compared with controls. After 4, 8, and 12 weeks, glucose (2.8, 8.3, or 16.7 mmol/kg) or the cholinergic agonist carbachol (0.16 or 0.53 micromol/kg) was injected intraperitoneally. The insulinotropic response to glucose was not different between the two groups after 4 or 8 weeks, whereas after 12 weeks, glucose-induced insulin secretion was markedly impaired in high-fat diet-treated mice (P < .001). In contrast, after 8 and 12 weeks on a high-fat diet, carbachol-stimulated insulin secretion was potentiated (P < .01), whereas carbachol-stimulated glucagon secretion was not significantly altered. Furthermore, after 12 weeks on the high-fat diet, insulin secretion from isolated islets was impaired at glucose levels of 8.3, 11.1, and 16.7 mmol/L (P < or = .05). Moreover, islet morphology as examined by immunocytochemistry using insulin antibodies and islet innervation, as revealed by immunostaining of tyrosine hydroxylase (TH), neuropeptide Y (NPY), galanin, vasoactive intestinal polypeptide (VIP), and substance P (SP) were unaffected by the high-fat diet for 12 weeks. However, quantitative in situ hybridization showed a 3.5-fold upregulation of insulin gene expression in response to the high-fat diet (P < .001) despite unaltered B-cell mass and pancreatic insulin content. We conclude that as little as 1 week of treatment with a high-fat diet induces insulin resistance in C57BL/6J mice. This is accompanied later by hyperlipemia, potentiated carbachol-stimulated insulin secretion, and increased insulin gene expression but impaired glucose-stimulated insulin secretion. We suggest that after several weeks' duration, insulin resistance is accompanied by enhanced islet sensitivity to cholinergic activation and exaggerated insulin gene expression, whereas the failing islet sensitivity to glucose represents decompensation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9005977     DOI: 10.1016/s0026-0495(97)90175-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  33 in total

Review 1.  Phospholipase A2 and its potential regulation of islet function.

Authors:  E Simonsson; B Ahrén
Journal:  Int J Pancreatol       Date:  2000-02

2.  Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation.

Authors:  R L Hull; K Kodama; K M Utzschneider; D B Carr; R L Prigeon; S E Kahn
Journal:  Diabetologia       Date:  2005-06-04       Impact factor: 10.122

Review 3.  Islet beta cell failure in type 2 diabetes.

Authors:  Marc Prentki; Christopher J Nolan
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

4.  Enhanced mitochondrial metabolism may account for the adaptation to insulin resistance in islets from C57BL/6J mice fed a high-fat diet.

Authors:  M Fex; M Dekker Nitert; N Wierup; F Sundler; C Ling; H Mulder
Journal:  Diabetologia       Date:  2006-11-09       Impact factor: 10.122

5.  Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet.

Authors:  Irene Morganstern; Olga Lukatskaya; Sang-Ho Moon; Wei-Ran Guo; Jane Shaji; Olga Karatayev; Sarah F Leibowitz
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

6.  Yi-Qi-Zeng-Min-Tang, a Chinese medicine, ameliorates insulin resistance in type 2 diabetic rats.

Authors:  Zeng Zhang; Hong-Li Xue; Yi Liu; Wen-Jian Wang
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

7.  Detrusor contractility to parasympathetic mediators is differentially altered in the compensated and decompensated states of diabetic bladder dysfunction.

Authors:  Nicole S Klee; Robert S Moreland; Derek M Kendig
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-29

8.  Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.

Authors:  M Sörhede Winzell; C L Brand; N Wierup; U G Sidelmann; F Sundler; E Nishimura; B Ahrén
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

9.  LKB1 deletion with the RIP2.Cre transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in vivo.

Authors:  Gao Sun; Andrei I Tarasov; James A McGinty; Paul M French; Angela McDonald; Isabelle Leclerc; Guy A Rutter
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-30       Impact factor: 4.310

10.  Progression of diet-induced diabetes in C57BL6J mice involves functional dissociation of Ca2(+) channels from secretory vesicles.

Authors:  Stephan C Collins; Michael B Hoppa; Jonathan N Walker; Stefan Amisten; Fernando Abdulkader; Martin Bengtsson; Jane Fearnside; Reshma Ramracheya; Ayo A Toye; Quan Zhang; Anne Clark; Dominique Gauguier; Patrik Rorsman
Journal:  Diabetes       Date:  2010-02-11       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.